Adaptive clinical trials in oncology (Q37953783)

25 August 2017

Adaptive clinical trials in oncology (English)

1 reference

25 August 2017

Donald A Berry

1

1 reference

PubMed ID

22064459

25 August 2017

language of work or name

English

0 references

publication date

8 November 2011

1 reference

Nature Reviews Clinical Oncology

25 August 2017

1 reference

25 August 2017

9

1 reference

25 August 2017

4

1 reference

25 August 2017

199-207

1 reference

Pattern recognition and massively distributed computing

25 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

A historical perspective on clinical trials innovation and leadership: where have the academics gone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

Detecting an overall survival benefit that is derived from progression-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

Progression-free survival is a surrogate for survival in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

21 January 2018

Bayesian clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

Adjuvant chemotherapy in older women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

A parallel phase I/II clinical trial design for combination therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

Dose‐Finding with Two Agents in Phase I Oncology Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

Development of novel combination therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

The relationship between progression-free and post-progression survival in treating four types of metastatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2011.165

10.1038/NRCLINONC.2011.165

31 March 2020

Identifiers

DOI

1 reference

release_kvgjacld55cslgwp67cnylu7x4

25 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kvgjacld55cslgwp67cnylu7x4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

22064459

1 reference

PubMed ID

22064459